Raymond James & Associates Penumbra Inc Call Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PEN
# of Institutions
374Shares Held
29.2MCall Options Held
305KPut Options Held
192K-
Black Rock Inc. New York, NY4.26MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$898 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.99MShares$485 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$378 Million1.9% of portfolio
-
State Street Corp Boston, MA1.24MShares$302 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $9.25B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...